TAMIR BIOTECHNOLOGY, INC.
Clinical stage antiviral therapeutics company.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination (No Activity) 4th Quarter 2017
|
FTI GOVERNMENT AFFAIRS | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2017
|
FTI GOVERNMENT AFFAIRS | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2017
|
FTI GOVERNMENT AFFAIRS | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2017
|
FTI GOVERNMENT AFFAIRS | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2016
|
FTI GOVERNMENT AFFAIRS | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2016
|
FTI GOVERNMENT AFFAIRS | — reported |
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2016
|
MS. REBECCA HALKIAS | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2016
|
FTI GOVERNMENT AFFAIRS | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2016
|
MS. REBECCA HALKIAS | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2016
|
FTI GOVERNMENT AFFAIRS | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FTI GOVERNMENT AFFAIRS | 13 | $40,000 |
| MS. REBECCA HALKIAS | 8 | $10,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Budget/Appropriations | BUD | 5 |
| Health Issues | HCR | 5 |
| Medical/Disease Research/Clinical Labs | MED | 5 |
| Disaster Planning/Emergencies | DIS | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.